Ad
related to: novartis
Search results
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
Zacks· 1 day agoNovartis (NVS) reports phase III data that confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria.
Novartis leukemia drug more effective than older treatments in trial
Reuters via Yahoo News· 1 day agoSwiss drugmaker Novartis said patients with a type of leukemia who took its Scemblix had a...
Novartis study points to larger role for targeted leukemia drug
BioPharma Dive via Yahoo Finance· 1 day agoThe results are from a late-stage clinical trial run by Scemblix’s maker, Novartis, and will be...
Novartis Sues to Block Maryland's New Drug Discount Law - Novartis (NYSE:NVS)
Benzinga· 18 hours agoNovartis AG NVS has reportedly filed a lawsuit to block a Maryland law requiring drugmakers to offer...
Novartis' Oral Drug For Chronic Skin Disease Candidate Shows Efficacy, Long-term Safety - Novartis...
Benzinga· 21 hours agoOn Friday, Novartis AG NVS released new data that confirm the long-term efficacy and safety of...
Novartis sues Maryland over law prohibiting restrictions on 340B drugs
Becker’s Hospital Review· 1 day ago"Novartis sues Maryland over new law restricting 340B drug pricing program, citing conflict with federal law and potential harm to constitutional rights."
Novartis reports Phase III data for trials of remibrutinib to treat CSU
Clinical Trials Arena via Yahoo Finance· 1 day agoNovartis has released new data from two Phase III clinical trials confirming the sustained efficacy...
Novartis stock rated 'Buy' by Goldman Sachs, highlighting robust innovation By Investing.com
Investing.com· 2 days agoOn Thursday, Goldman Sachs (NYSE:GS) initiated coverage on Novartis AG (SIX:NOVN) stock, listed as...
Novartis (NVS) Presents Positive Data on Renal Drugs at ERA
Zacks· 5 days agoNovartis (NVS) presents data on Fabhalta in adult patients with C3 glomerulopathy and atrasentan in...
Novartis sues Maryland over law mandating discounts for hospitals' outside pharmacies
Reuters· 2 days agoLike other...